Skip to main content
. 2021 Sep 16;9:720349. doi: 10.3389/fcell.2021.720349

FIGURE 7.

FIGURE 7

Our study demonstrated that BRCC3 could promote BCa cells proliferation and migration both in vitro and in vivo. Furthermore, BRCC3 exerts its oncogenic role via binding to TRAF2, which in turn activates NF-κB signaling and inflammation in bladder cancer.